Life After Cancer

Cancervive is an organization that helps cancer survivors overcome the challenges of “life after cancer.” In addition to support groups, they provide educational materials, insurance information and assistance and advocacy.

At first, I didn’t get it. Why worry about life after cancer? What’s there to worry about?

For some families, having a child with cancer has wiped them out financially and college scholarships specifically targeting young cancer survivors can help.

The Cancer Survival Fund can help (http://www.cancersurvivorsfund.org/) They envision to reach every young cancer survivor who is actively seeking for a scholarship and/or financial assistance to obtain prosthetics needing our help to continue their education for personal growth and better, brighter future.

What about a caregiver fired for providing care for a loved one with cancer? Cancervive’s legal counsel offers support and advice like this: “It is illegal to discriminate against someone who has a handicapping condition, and also against someone, such as yourself, who is assisting or wants to assist someone who has a handicapping condition” and tells readers what to do next.

Cancervive

800-486-2873

www.cancervive.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap